The ability of RBP to penetrate cells, inhibit RAS–RAF interaction and signaling, and suppress cancer cell migration, proliferation, and metastasis highlights its potential as a versatile and effective treatment strategy for RAS-mutated cancer cells. This evidence concerns the gene RAF1 and cancer.